Guiting Zhan
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 4
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 9
- Materials Chemistry top 10%
- Advanced Nanomaterials in Catalysis 3
- Mesoporous Materials and Catalysis 2
- Immunology top 10%
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
-
- Extracellular vesicles in disease 3
-
- Photodynamic Therapy Research Studies 2
- Partner nations
- ChinaPakistanUnited States
In The Last Decade
Guiting Zhan
13 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Biomaterials 429
- Biomedical Engineering 1.3k
- Materials Chemistry 686
- Immunology 300
- Cancer Research 111
Countries citing papers authored by Guiting Zhan
This map shows the geographic impact of Guiting Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiting Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiting Zhan more than expected).
Fields of papers citing papers by Guiting Zhan
This network shows the impact of papers produced by Guiting Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiting Zhan. The network helps show where Guiting Zhan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guiting Zhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblastsbreakdown → | 2022 | 200 |
| 2 | 2022 | 20 | |
| 3 | 2022 | 54 | |
| 4 | Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticlesbreakdown → | 2021 | 271 |
| 5 | 2021 | 104 | |
| 6 | 2021 | 31 | |
| 7 | Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumorsbreakdown → | 2020 | 240 |
| 8 | 2020 | 96 | |
| 9 | 2019 | 153 | |
| 10 | GSH‐Depleted PtCu3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapybreakdown → | 2019 | 488 |
| 11 | 2019 | 55 | |
| 12 | 2018 | 52 | |
| 13 | 2018 | 43 |
About Guiting Zhan
Guiting Zhan is a scholar working on Biomaterials, Biomedical Engineering and Immunology, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced Nanomaterials in Catalysis (3 papers), Extracellular vesicles in disease (3 papers), Immune cells in cancer (3 papers), Mesoporous Materials and Catalysis (2 papers), Phagocytosis and Immune Regulation (2 papers) and Photodynamic Therapy Research Studies (2 papers). The work is most often cited by research in Biomaterials (429 citations), Biomedical Engineering (1.3k citations) and Materials Chemistry (686 citations). Guiting Zhan has collaborated with scholars based in China, Pakistan and United States. Frequent co-authors include Xiangliang Yang, Lu Gan, Tuying Yong, Jun Hu, Yongan Tang, Xiaoyan Zhong, Liang Cheng, Xianwen Wang, Qingbo Xu and Zhaohan Wei. Their work appears in journals such as Nature Communications, Nano Today, ACS Nano, Journal of Materials Chemistry B and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.